GILDESS 1.5/30 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gildess 1.5/30, and when can generic versions of Gildess 1.5/30 launch?
Gildess 1.5/30 is a drug marketed by Vintage Pharms Llc and is included in one NDA.
The generic ingredient in GILDESS 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for GILDESS 1.5/30
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GILDESS 1.5/30 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for GILDESS 1.5/30
US Patents and Regulatory Information for GILDESS 1.5/30
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vintage Pharms Llc | GILDESS 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 077075-002 | Jul 24, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |